Atlas Trials

Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1

Clinical trial NCT02251457 · COMPLETED

Trial details

NCT number
NCT02251457
Sponsor
Ohio State University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Myotonia CongenitaParamyotonia CongenitaMyotonic Dystrophy 1
Start date
2014-08-01
Primary completion
2017-12-18
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.